Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The Dynamics of SARS-CoV-2 Infectivity with Changes in Aerosol Microenvironment

Henry P. Oswin, Allen E. Haddrell, Mara Otero-Fernandez, Jamie F.S. Mann, Tristan A. Cogan, Tom Hilditch, Jianghan Tian, Dan Hardy, Darryl J. Hill, Adam Finn, Andrew D. Davidson, Jonathan P. Reid
doi: https://doi.org/10.1101/2022.01.08.22268944
Henry P. Oswin
1School of Chemistry, Cantock’s Close, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allen E. Haddrell
1School of Chemistry, Cantock’s Close, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: J.P.Reid@bristol.ac.uk Andrew.Davidson@bristol.ac.uk A.Haddrell@bristol.ac.uk
Mara Otero-Fernandez
1School of Chemistry, Cantock’s Close, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamie F.S. Mann
2Bristol Veterinary School, University of Bristol, Langford House, Langford, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tristan A. Cogan
2Bristol Veterinary School, University of Bristol, Langford House, Langford, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Hilditch
1School of Chemistry, Cantock’s Close, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianghan Tian
1School of Chemistry, Cantock’s Close, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Hardy
1School of Chemistry, Cantock’s Close, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darryl J. Hill
3School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Finn
3School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew D. Davidson
3School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: J.P.Reid@bristol.ac.uk Andrew.Davidson@bristol.ac.uk A.Haddrell@bristol.ac.uk
Jonathan P. Reid
1School of Chemistry, Cantock’s Close, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: J.P.Reid@bristol.ac.uk Andrew.Davidson@bristol.ac.uk A.Haddrell@bristol.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Understanding the factors that influence the airborne survival of viruses such as SARS-CoV-2 in aerosols is important for identifying routes of transmission and the value of various mitigation strategies for preventing transmission. We present measurements of the stability of SARS-CoV-2 in aerosol droplets (∼5-10µm equilibrated radius) over timescales spanning from 5 seconds to 20 minutes using a novel instrument to probe survival in a small population of droplets (typically 5-10) containing ∼1 virus/droplet. Measurements of airborne infectivity change are coupled with a detailed physicochemical analysis of the airborne droplets containing the virus. A decrease in infectivity to ∼10 % of the starting value was observable for SARS-CoV-2 over 20 minutes, with a large proportion of the loss occurring within the first 5 minutes after aerosolisation. The initial rate of infectivity loss was found to correlate with physical transformation of the equilibrating droplet; salts within the droplets crystallise at RHs below 50% leading to a near instant loss of infectivity in 50–60% of the virus. However, at 90% RH the droplet remains homogenous and aqueous, and the viral stability is sustained for the first 2 minutes, beyond which it decays to only 10% remaining infectious after 10 minutes. The loss of infectivity at high RH is consistent with an elevation in the pH of the droplets, caused by volatilisation of CO2 from bicarbonate buffer within the droplet. Three different variants of SARS-CoV-2 were compared and found to have a similar degree of airborne stability at both high and low RH.

Significance The aerosol microenvironment is highly dynamic exposing pathogens, such as the SARS-CoV-2 virus when exhaled in respiratory aerosol, to extreme conditions of solute concentration, pH and evaporative cooling. Yet surviving this environment is a key step in the transmission of such pathogens. Understanding the impact that airborne transport has on pathogens and the influence of environmental conditions on pathogen survival can inform the implementation of strategies to mitigate the spread of diseases such as COVID-19. We report changes in the infectivity of the airborne virus over timescales spanning from 5 s to 20 minutes and demonstrate the role of two microphysical processes in this infectivity loss: particle crystallisation and aerosol droplet pH change.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by the NIHR-UKRI rapid COVID-19 call, the Elizabeth Blackwell Institute for Health Research, the University of Bristol, and the Medical Research Council. Additionally, this work was supported by funding from the PROTECT COVID-19 National Core Study on transmission and environment, managed by the Health and Safety Executive on behalf of HM Government. AH and MOF received funding from the BBSRC, project BB/T011688/1. HO is supported by funding from DSTL and EPSRC.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted January 10, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The Dynamics of SARS-CoV-2 Infectivity with Changes in Aerosol Microenvironment
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Dynamics of SARS-CoV-2 Infectivity with Changes in Aerosol Microenvironment
Henry P. Oswin, Allen E. Haddrell, Mara Otero-Fernandez, Jamie F.S. Mann, Tristan A. Cogan, Tom Hilditch, Jianghan Tian, Dan Hardy, Darryl J. Hill, Adam Finn, Andrew D. Davidson, Jonathan P. Reid
medRxiv 2022.01.08.22268944; doi: https://doi.org/10.1101/2022.01.08.22268944
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The Dynamics of SARS-CoV-2 Infectivity with Changes in Aerosol Microenvironment
Henry P. Oswin, Allen E. Haddrell, Mara Otero-Fernandez, Jamie F.S. Mann, Tristan A. Cogan, Tom Hilditch, Jianghan Tian, Dan Hardy, Darryl J. Hill, Adam Finn, Andrew D. Davidson, Jonathan P. Reid
medRxiv 2022.01.08.22268944; doi: https://doi.org/10.1101/2022.01.08.22268944

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (141)
  • Cardiovascular Medicine (1960)
  • Dentistry and Oral Medicine (253)
  • Dermatology (186)
  • Emergency Medicine (334)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (702)
  • Epidemiology (11120)
  • Forensic Medicine (8)
  • Gastroenterology (629)
  • Genetic and Genomic Medicine (3193)
  • Geriatric Medicine (310)
  • Health Economics (566)
  • Health Informatics (2048)
  • Health Policy (864)
  • Health Systems and Quality Improvement (789)
  • Hematology (310)
  • HIV/AIDS (684)
  • Infectious Diseases (except HIV/AIDS) (12739)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (318)
  • Medical Ethics (92)
  • Nephrology (337)
  • Neurology (3000)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1561)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (384)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2795)
  • Public and Global Health (5610)
  • Radiology and Imaging (1100)
  • Rehabilitation Medicine and Physical Therapy (636)
  • Respiratory Medicine (764)
  • Rheumatology (341)
  • Sexual and Reproductive Health (314)
  • Sports Medicine (289)
  • Surgery (347)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)